Literature DB >> 7199959

Production of tolerance and physical dependence in the rat by simple administration of morphine in drinking water.

A A Badawy, C M Evans, M Evans.   

Abstract

1 Rats are capable of consuming solutions of morphine sulphate in drinking water ad libitum in the absence of taste-masking chemicals and without the need for scheduled provision or prior parenteral administration of the drug. 2 The success of this method depends on the initial provision of a 0.1 mg/ml solution of morphine sulphate. 3 When the drug concentration is increased to 0.4 mg/ml, the rats achieve an average daily intake of 50 mg/kg body wt. each. 4 Daily intake of morphine may be increased by at least about three fold by increasing the drug concentration to 1.2 mg/ml. 5 Oral morphine administration causes only a moderate loss in body weight. 6 Rats whose daily intake of the drug is 50 mg/kg exhibit tolerance to the analgesic action of morphine and show a drastic loss in body weight at 24 h after withdrawal and most of the behavioural symptoms of the naloxone-precipitated withdrawal syndrome. 7 It is suggested that this simple method of morphine administration is suitable for further biochemical and behavioural studies of the actions of the drug.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7199959      PMCID: PMC2071578          DOI: 10.1111/j.1476-5381.1982.tb09165.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  The production of morphine tolerance and physical dependence by the oral route in the rat. A comparative study.

Authors:  V O Fuentes; W B Hunt; J Crossland
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

2.  Drug addiction. I. Addiction by escape training.

Authors:  H W COPPOCK; C P HEADLEE; J R NICHOLS
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1956-12

3.  The effects of ethanol on tryptophan pyrrolase activity and their comparison with those of phenobarbitone and morphine.

Authors:  A A Badawy; M Evans
Journal:  Adv Exp Med Biol       Date:  1975       Impact factor: 2.622

4.  Oral ingestion of narcotic analgesics by rats.

Authors:  D E McMillan; J D Leander; T W Wilson; S C Wallace; T Fix; S Redding; R T Turk
Journal:  J Pharmacol Exp Ther       Date:  1976-02       Impact factor: 4.030

5.  Quasi morphine-abstinence syndrome.

Authors:  H O Collier; D L Francis; G Henderson; C Schneider
Journal:  Nature       Date:  1974-05-31       Impact factor: 49.962

6.  Preferences for morphine in rats: validation of an experimental model of dependence.

Authors:  I P Stolerman; R Kumar
Journal:  Psychopharmacologia       Date:  1970

7.  Quantitative assessment of tolerance to and dependence on morphine in mice.

Authors:  M Fernandes; S Kluwe; H Coper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

8.  The role of liver tryptophan pyrrolase in the opposite effects of chronic administration and subsequent withdrawal of drugs of dependence on rat brain tryptophan metabolism.

Authors:  A A Badawy; N F Punjani; M Evans
Journal:  Biochem J       Date:  1981-04-15       Impact factor: 3.857

9.  Unsuitability of control sucrose or glucose in studies of the effects of chronic ethanol administration on brain 5-hydroxytryptamine metabolism.

Authors:  A A Badawy; N F Punjani; M Evans
Journal:  J Pharmacol Methods       Date:  1980-02

10.  Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions.

Authors:  V F Gellert; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1978-06       Impact factor: 4.030

View more
  15 in total

1.  The effect of opioids on the development of postoperative intra-abdominal adhesions.

Authors:  Amir Khorram-Manesh; Jalal Vahedian Ardakani; Hamid Reza Behjati; Gunnar Nylund; Dick Delbro
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

2.  Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine.

Authors:  M Barrios; J M Baeyens
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Role of phosphodiesterase inhibitor Ibudilast in morphine-induced hippocampal injury.

Authors:  Mohsen Zhaleh; Marzieh Panahi; Mehri Ghafurian Broujerdnia; Rostam Ghorbani; Kambiz Ahmadi Angali; Ghasem Saki
Journal:  J Inj Violence Res       Date:  2013-10-11

4.  Chronic morphine drinking establishes morphine tolerance, but not addiction in Wistar rats.

Authors:  Ralf Binsack; Ming-lan Zheng; Zhan-sai Zhang; Liu Yang; Yong-ping Zhu
Journal:  J Zhejiang Univ Sci B       Date:  2006-11       Impact factor: 3.066

5.  Naloxone-induced cardiovascular depression in rats that had received chronic morphine-treatment.

Authors:  S Dai; Y Wang
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

6.  Effect of opium dependency on secondary intention wound healing in a rat model: an experimental study.

Authors:  Jalal Vahedian; Tooraj-Reza Mirshekari; Fatemeh Nabavizadeh
Journal:  Int Wound J       Date:  2012-05-28       Impact factor: 3.315

7.  Effects of morphine on cardiovascular responses to acute myocardial ischaemia in rats.

Authors:  M Y Chan; S Dai; W W Ko
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

Review 8.  Are astroglial cells involved in morphine tolerance?

Authors:  L Rönnbäck; E Hansson
Journal:  Neurochem Res       Date:  1988-02       Impact factor: 3.996

9.  Modulation of brain alpha 2-adrenoceptor and mu-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats.

Authors:  I Ulibarri; J A García-Sevilla; L Ugedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

10.  Prevention by the 5-HT3 receptor antagonist, ondansetron, of morphine-dependence and tolerance in the rat.

Authors:  S C Hui; E L Sevilla; C W Ogle
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.